Altered levels of α-synuclein and sphingolipids in Batten disease lymphoblast cells

Gene

Volumn 539, Issue 2, 2014, Pages 181-185

  Kang, Sunyang ^a   Heo, Tae Hwe ^b   Kim, Sung Jo ^a  

^a Hoseo University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Synuclein; Apoptosis; Autophagy; Batten disease; Gangliosides; Sphingomyelin

Indexed keywords

ACRIDINE ORANGE; ALPHA SYNUCLEIN; GANGLIOSIDE; OLIGOMER; SPHINGOMYELIN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; LYMPHOBLAST; NEURONAL CEROID LIPOFUSCINOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STAINING; THIN LAYER CHROMATOGRAPHY; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; AUTOPHAGY; BATTEN DISEASE; GANGLIOSIDES; SPHINGOMYELIN; Α-SYNUCLEIN;

ALPHA-SYNUCLEIN; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; G(M1) GANGLIOSIDE; G(M2) GANGLIOSIDE; G(M3) GANGLIOSIDE; HUMANS; LYMPHOCYTES; NEURONAL CEROID-LIPOFUSCINOSES; PROTEIN MULTIMERIZATION; SPHINGOLIPIDS; SPHINGOMYELINS;

EID: 84896738808     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.02.017     Document Type: Article

References (33)

1. Andrieu-Abadie N., Levade T. Sphingomyelin hydrolysis during apoptosis. Biochimica et Biophysica Acta 2002, 1585:126-134.
2. Benedict J.W., Sommers C.A., Pearce D.A. Progressive oxidative damage in the central nervous system of a murine model for juvenile Batten disease. Journal of Neuroscience Research 2007, 85:2882-2891.
3. Burré J., Sharma M., Tsetsenis T., Buchman V., Etherton M.R., Südhof T.C. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 2010, 329:1663-1667.
4. Canals D., Perry D.M., Jenkins R.W., Hannun Y.A. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases. British Journal of Pharmacology 2011, 163:694-712.
5. Cao Y. Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. Journal of Biological Chemistry 2006, 281:20483-20493.
6. Chandra S., Gallardo G., Fernández-Chacón R., Schlüter O.M., Südhof T.C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 2005, 123:383-396.
7. Cookson M.R. α-Synuclein and neuronal cell death. Molecular Neurodegeneration 2009, 4:9.
8. Cooper A.A. Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006, 313:324-328.
9. Fantini J., Yahi N. Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion. Journal of Molecular Biology 2011, 408:654-669.
10. Kang S., Kim J.-B., Heo T.H., Kim S.-J. Cell cycle arrest in Batten disease lymphoblast cells. Gene 2013, 519:245-250.
11. Kang S., Seo J.H., Heo T.-H., Kim S.-J. Batten disease is linked to altered expression of mitochondria-related metabolic molecules. Neurochemistry International 2013, 62:931-935.
12. Kim J.-B., Lim N., Kim S.-J., Heo T.-H. N-acetylcysteine normalizes the urea cycle and DNA repair in cells from patients with Batten disease. Cell Biochemistry and Function 2012, 30:677-682.
13. Klucken J., et al. Alpha-synuclein aggregation involves a bafilomycin A1-sensitive autophagy pathway. Autophagy 2012, 8:754-766.
14. Koike M., et al. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). The American Journal of Pathology 2005, 167:1713-1728.
15. Lavieu G., et al. Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation. The Journal of Biological Chemistry 2006, 281:8518-8527.
16. Lieberman A.P., Puertollano R., Raben N., Slaugenhaupt S., Walkley S.U., Ballabio A. Autophagy in lysosomal storage disorders. Autophagy 2012, 8:719-730.
17. Martinez Z., Zhu M., Han S., Fink A.L. GM1 specifically interacts with α-synuclein and inhibits fibrillation †. Biochemistry 2007, 46:1868-1877.
18. Mazzulli J.R., et al. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011, 146:37-52.
19. Osório N.S., et al. Nitric oxide signaling is disrupted in the yeast model for Batten disease. Molecular Biology of the Cell 2007, 18:2755-2767.
20. Persaud-Sawin D.A., Boustany R.-M.N. Cell death pathways in juvenile Batten disease. Apoptosis 2005, 10:973-985.
21. Persaud-Sawin D.-A.N.W., Vandongen A., Boustany R.-M.N. Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis. Human Molecular Genetics 2002, 11:2129-2142.
22. Puranam K., et al. Upregulation of Bcl-2 and elevation of ceramide in batten disease. Neuropediatrics 2007, 28:37-41.
23. Rippo M.R., et al. GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion. FASEB Journal 2000, 14:2047-2054.
24. Rusyn E., Mousallem T., Persaud-Sawin D.-A., Miller S., Boustany R.-M.N. CLN3p impacts galactosylceramide transport, raft morphology, and lipid content. Pediatric Research 2008, 63:625-631.
25. Saha A.R., Ninkina N.N., Hanger D.P., Anderton B.H., Davies A.M., Buchman V.L. Induction of neuronal death by alpha-synuclein. The European Journal of Neuroscience 2000, 12:3073-3077.
26. Soreghan B., Thomas S.N., Yang A.J. Aberrant sphingomyelin/ceramide metabolic-induced neuronal endosomal/lysosomal dysfunction: potential pathological consequences in age-related neurodegeneration. Advanced Drug Delivery Reviews 2003, 55:1515-1524.
27. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nature Reviews. Molecular Cell Biology 2003, 4:397-407.
28. Suzuki K., et al. Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model. Neuroreport 2003, 14:551-554.
29. Tuxworth R.I., Chen H., Vivancos V., Carvajal N., Huang X., Tear G. The Batten disease gene CLN3 is required for the response to oxidative stress. Human Molecular Genetics 2011, 20:2037-2047.
30. Uversky V.N. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. Journal of Neurochemistry 2007, 103:17-37.
31. Wei H., Kim S.J., Zhang Z., Tsai P.C., Wisniewski K.E., Mukherjee A.B. ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. Human Molecular Genetics 2007, 17:469-477.
32. Xu Y.H., Barnes S., Sun Y., Grabowski G.A. Multi-system disorders of glycosphingolipid and ganglioside metabolism. The Journal of Lipid Research 2010, 51:1643-1675.
33. Young M.M., Kester M., Wang H.-G. Sphingolipids: regulators of crosstalk between apoptosis and autophagy. The Journal of Lipid Research 2013, 54:5-19.